T cell activation mediated by the TCR is triggered by a complex of an antigenic peptide with a cell surface protein encoded by the MHC. The specific control of the trimolecular interaction between a particular antigen, MHC molecule, and TCR follows a set of genetically programmed parameters . MHC polymorphisms regulate one of these parameters, termed MHC restriction, by which some MHC alleles form "permissive" complexes that permit T cell response, and other MHC alleles do not. Recent studies using murine class II MHC molecules (1-2) have demonstrated that the act of binding a peptide is necessary, but not always sufficient to trigger potentially reactive T cells; presumably, precise structural interactions between amino acids on the peptide and on the class II molecule itself are crucial for recognition. Structural variation among class II molecules can be critically important for this function . In the example of the H-26 "12 mouse, three amino acid substitutions in the class II Ia (3 chain distinguish the bm12 strain from the parental B6 strain, and apparently confer a wide variety of distinct immunologic characteristics, including alloreactivity against the parental B6, differential responsiveness to defined antigenic peptides, and differential susceptibility to experimentally induced myasthenia gravis (3-5).As the bm12 mouse example illustrates, specific substitutions in class 11 0 chains may have dramatic consequences for immune function . Among human class II molecules, both the class II a and the class 11 0 chains in functional class II dimers potentially contribute structural variation affecting function, particularly at the HLA-DQ locus, where both a and a genes are highly polymorphic. Structural models of recognition events involving HLA class II molecules suggest that polymorphic sites on a and /3 chains potentially interact with each other, with peptide, and with TCR (6-7).To evaluate the fine structural requirements ofthis interaction, we analyzed human T cell-MHC interactions in vitro by evaluating the effects of specific molecular substitutions within the class II HLA-DQ a and /3 chain components . We have previously described the use of site-directed mutagenesis on cloned human MHC genes,